John B. Lynch, MD, MPH | Allergy and Infectious Diseases

Associate Professor

Department of Medicine, Division of Allergy & Infectious Diseases

Medical Director, HMC Infection Prevention & Control

Medical Director, HMC Employee Health

Medical Director, HMC Antimicrobial Stewardship Program

Sites of Practice:

Harborview Medical Center

Faculty Information

Biography

Dr. Lynch's focus is on the prevention of healthcare associated infections (HAI), rational use of antimicrobials, and employee health at Harborview Medical Center. In addition, he is an atttending physician in HMC Infectious Diseases Clinic where he sees patients with a broad spectrum of infectious diseases.

Current and recent research projects are focused on the epidemiology of HAI, appropriate infectious disease diagnosis, testing and treatment pathways, risk factors for Clostridium difficile infection, the use of antimicrobials, healthcare worker influenza vaccination, and preventable injury of healthcare workers.

Education & Training:

University of Washington

Seattle, WA

2001

MPH, Epidemiology/Global Health

University of Washington

Seattle, WA

2011

Fellow in Infectious Diseases

University of Washington

Seattle, WA

2005-2009

Post-doctoral Fellow, Overbaugh Lab

Fred Hutchinson Cancer Research Center

Seattle, WA

2006-2009

Honors:

Alpha Omega Alpha Medical Honor Society

Morton N. Swartz Humanism in Medicine Award, Massachusetts General Hospital

Harborview Medical Center CARES Award, Infection Control Program

Contact

Email:

jblynch@uw.edu

Phone:

(206) 744-5180

Mailing Address:

Harborview Medical Center
325 9th Ave
Box 359778
Seattle, WA 98104

Research & Clinical Interests

Research Interests:

Healthcare-associated infections
Infection prevention & control
Antimicrobial stewardship
Antimicrobial resistance

Clinical Interests:

General ID
Healthcare-associated infections
Multi-drug resistant bacterial infections

Publications

PubMed:

PubMed Bibliography

Publications:

Lynch JB. Multidrug-resistant Tuberculosis. Med Clin North Am. 2013 Jul; 97(4):553-79,ix-x.
• PubMed Abstract

Evans HL, McNamara E, Lynch JB, Chan JD, Dellit TH. Infection control for critically ill trauma patients: a systematic approach to prevention, detection and provider feedback. Crit Care Nurs Q. 2012 Jul-Sep; 35(3):241-6.
• PubMed Abstract

Chan JD, Dellit TH, Choudhuri JA,McNamara E, Melius EJ, Evans HL, Cuschieri J, Arbabi S, Lynch, JB. Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med. 2012; 40(5):1437-42.
• PubMed Abstract

Clemens EC, Chan JC, Lynch JB, Dellit TH. Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol and Infect Dis. 2011; 71(4):408-14.
• PubMed Abstract

Choudhuri J, Pergamit R, Chan J, Schreuder AB, McNamara E, Lynch JB, Dellit TH. An electronic catheter-associated urinary tract infection surveillance tool. Infect Control Hosp Epidemiol. 2011; 32(8):757-62.
• PubMed Abstract

Lynch JB, Blish CA, John-Stewart G, Richardson B, Overbaugh J. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies does not correlate with risk of infant infection. J Virol. 2011; 85(11):5252-61.
• PubMed Abstract

Gulati RK, Choudhuri J, Fulton C, Chan JD, Evans HL, Lynch JB, Dellit TH. Outbreak of carbapenem-resistant Acinetobacter baumannii among non-burn patients in a burn intensive care unit. J Hosp Infect. 2010; 76(4):357-8.
• PubMed Abstract

Printer-friendly